VERAXA Biotech Appoints Carl von Halem as Interim CFO Amid Permanent Search

VERAXA Biotech AG (NASDAQ: VRXA) announced the appointment of Carl von Halem as interim chief financial officer, succeeding Torsten Bürgermeister. The company is in the final stages of discussions with a permanent CFO candidate expected to support its next phase of expansion and operational growth, with an update to be provided in due course.

Von Halem currently serves as chief financial officer of Xlife Sciences and played a key role in VERAXA’s public listing. The company cited his experience in corporate finance, life sciences and technology-driven businesses, as well as his familiarity with VERAXA’s operations and strategic development, as key qualifications for leading the finance function during the transition. This appointment ensures continuity in financial leadership as VERAXA advances its pipeline of antibody-based therapeutics.

VERAXA is building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including bispecific T cell engagers, bispecific ADCs and other innovative formats. Powered by a suite of transformative technologies and guided by rigorous quality-by-design principles, the company is rapidly advancing its pipeline of ADCs and proprietary BiTAC formats into clinical development and beyond. VERAXA was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL), a world-renowned institution known for pioneering life science research and cutting-edge technology.

The appointment of an interim CFO with deep knowledge of the company’s operations and strategic goals is critical as VERAXA navigates its next growth phase. Von Halem’s prior involvement in the public listing provides him with unique insights into the company’s financial structure and investor relations. The company’s search for a permanent CFO underscores its commitment to strengthening its leadership team to support ongoing research and development efforts.

For more details, the full press release is available at https://nnw.fm/BjjY6. The latest news and updates relating to VRXA are available in the company’s newsroom at http://nnw.fm/VRXA.